BioXcel Therapeutics, Inc.
NASDAQ:BTAI
0.3511 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.214 | 1.104 | 0.582 | 0.376 | 0.341 | 0.457 | 0.206 | 0.238 | 0.137 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.17 | 0.062 | 0.158 | 0.792 | 0.512 | 0.026 | 0.009 | 0.009 | 0.011 | 0.084 | 0.077 | 0.076 | 0.076 | 0.08 | 0.065 | 0 | 0 | 14.794 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.956 | 1.042 | 0.424 | -0.416 | -0.171 | 0.431 | 0.197 | 0.229 | 0.126 | -0.084 | -0.077 | -0.076 | -0.076 | -0.08 | -0.065 | 0 | 0 | -14.794 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| -4.467 | 0.944 | 0.729 | -1.106 | -0.501 | 0.943 | 0.956 | 0.962 | 0.92 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 5.101 | 8.032 | 11.137 | 9.731 | 19.619 | 26.973 | 27.8 | 32.459 | 22.062 | 17.906 | 18.559 | 12.525 | 11.933 | 13.509 | 14.741 | 11.401 | 16.317 | 17.906 | 12.371 | 6.495 | 7.122 | 6.506 | 5.674 | 6.018 | 3.821 | 1.781 | 2.938 | 1.426 | 0.619 | 0.324 | 0.321 |
| General & Administrative Expenses
| 0 | 9.145 | 13.264 | 9.284 | 21.355 | 21.064 | 23.595 | 20.664 | 17.054 | 18.382 | 12.921 | 13.606 | 14.879 | 11.153 | 9.643 | 9.696 | 8.451 | 3.529 | 2.625 | 1.918 | 2.012 | 2.129 | 1.745 | 1.295 | 1.298 | 1.463 | 1.348 | 1.1 | 0.298 | 0.241 | 0.208 |
| Selling & Marketing Expenses
| 0 | 0.305 | -0.048 | 0.319 | 2.989 | 4.808 | 2.598 | 31.043 | 2.738 | 4.719 | 0 | -4.946 | 0 | 2.951 | 1.995 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.683 | 9.45 | 13.216 | 9.581 | 24.344 | 25.872 | 23.595 | 20.664 | 17.054 | 18.382 | 12.921 | 13.606 | 14.879 | 14.104 | 11.638 | 9.696 | 8.451 | 3.529 | 2.625 | 1.918 | 2.012 | 2.129 | 1.745 | 1.295 | 1.298 | 1.463 | 1.348 | 1.1 | 0.298 | 0.241 | 0.208 |
| Other Expenses
| 1.553 | 0 | 0.032 | 0.108 | -0.005 | 0.537 | -0.246 | -0.48 | 0.062 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 14.337 | 17.023 | 24.353 | 19.312 | 43.963 | 52.845 | 51.395 | 53.123 | 39.116 | 36.288 | 31.48 | 26.131 | 26.812 | 27.613 | 26.379 | 21.097 | 24.768 | 21.435 | 14.996 | 8.413 | 9.134 | 8.635 | 7.419 | 7.313 | 5.119 | 3.244 | 4.286 | 2.526 | 0.917 | 0.565 | 0.529 |
| Operating Income
| -15.293 | -16.058 | -23.929 | -19.728 | -48.297 | -52.414 | -51.198 | -52.894 | -38.99 | -36.288 | -31.48 | -26.131 | -26.812 | -27.613 | -26.379 | -21.097 | -24.768 | -21.435 | -14.996 | -8.413 | -9.134 | -8.635 | -7.419 | -7.313 | -5.119 | -3.244 | -4.286 | -2.526 | -0.917 | -0.565 | -0.529 |
| Operating Income Ratio
| -71.463 | -14.545 | -41.115 | -52.468 | -141.633 | -114.691 | -248.534 | -222.244 | -284.599 | 0 | 0 | 0 | 0 | 0 | 0 | -868,419,842.65 | -2,930,777,422.79 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.643 | 7.759 | -2.862 | -2.528 | -6.352 | -1.101 | -1.598 | -1.914 | -2.815 | -1.382 | 0.008 | 0.006 | 0.001 | -0.006 | 0.003 | 0.011 | 0.015 | 0.016 | 0.085 | 0.138 | 0.116 | 0.164 | 0.215 | 0.238 | 0.232 | 0.218 | 0.004 | -0.002 | 0 | 0 | 0 |
| Income Before Tax
| -13.65 | -8.299 | -26.791 | -22.256 | -50.486 | -53.515 | -52.796 | -54.808 | -41.805 | -37.67 | -31.472 | -26.125 | -26.811 | -27.619 | -26.376 | -21.086 | -24.753 | -21.419 | -14.911 | -8.275 | -9.018 | -8.471 | -7.204 | -7.075 | -4.887 | -3.026 | -4.282 | -2.528 | -0.917 | -0.565 | -0.529 |
| Income Before Tax Ratio
| -63.785 | -7.517 | -46.033 | -59.191 | -148.053 | -117.101 | -256.291 | -230.286 | -305.146 | 0 | 0 | 0 | 0 | 0 | 0 | -867,967,047.548 | -2,929,002,484.913 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.035 | -5.274 | 3.247 | 3.796 | -1.769 | 3.277 | 2.815 | 1.382 | -0.008 | 106.855 | 0.012 | 0.01 | 0.01 | -0.041 | 0.005 | -0.016 | -0.085 | -0.076 | -0.116 | -0.164 | -0.215 | -0.238 | -0.232 | -0.218 | -0 | 0 | 0 | 0.001 | 0 |
| Net Income
| -13.65 | -8.299 | -26.791 | -22.256 | -50.486 | -53.515 | -51.027 | -58.085 | -44.62 | -39.052 | -31.464 | -26.125 | -26.811 | -27.619 | -26.376 | -21.086 | -24.753 | -21.419 | -14.911 | -8.275 | -9.018 | -8.471 | -7.204 | -7.075 | -4.887 | -3.026 | -4.282 | -2.528 | -0.917 | -0.565 | -0.529 |
| Net Income Ratio
| -63.785 | -7.517 | -46.033 | -59.191 | -148.053 | -117.101 | -247.704 | -244.055 | -325.693 | 0 | 0 | 0 | 0 | 0 | 0 | -867,967,047.548 | -2,929,002,484.913 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.32 | -0.21 | -0.87 | -0.76 | -1.72 | -1.83 | -1.78 | -2.07 | -1.59 | -1.4 | -1.12 | -0.93 | -0.96 | -1.11 | -1.08 | -0.87 | -1.07 | -1.06 | -0.79 | -0.46 | -0.57 | -0.54 | -0.46 | -0.45 | -0.31 | -0.19 | -0.37 | -0.22 | -0.059 | -0.036 | -0.034 |
| EPS Diluted
| -0.32 | -0.21 | -0.87 | -0.76 | -1.72 | -1.83 | -1.78 | -2.07 | -1.59 | -1.4 | -1.12 | -0.93 | -0.96 | -1.11 | -1.08 | -0.87 | -1.07 | -1.06 | -0.79 | -0.44 | -0.57 | -0.54 | -0.46 | -0.45 | -0.31 | -0.19 | -0.37 | -0.22 | -0.059 | -0.036 | -0.034 |
| EBITDA
| -9.783 | -4.522 | -23.106 | -18.743 | -47.155 | -50.103 | -49.349 | -51.806 | -38.436 | -36 | -31.403 | -26.049 | -26.762 | -27.534 | -26.311 | -21.041 | -24.7 | -21.371 | -14.864 | -8.413 | -8.922 | -8.55 | -7.382 | -7.305 | -5.112 | -3.243 | -4.286 | -2.526 | -0.916 | -0.565 | -0.528 |
| EBITDA Ratio
| -45.715 | -4.096 | -40.981 | -52.261 | -126.076 | -109.792 | -239.947 | -218.013 | -284.599 | 0 | 0 | 0 | 0 | 0 | 0 | -868,419,842.65 | -2,925,097,621.583 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |